Status:
TERMINATED
Allosure in Simultaneous Pancreas Kidney Transplant
Lead Sponsor:
Washington University School of Medicine
Collaborating Sponsors:
CareDx
University of Texas
Conditions:
Kidney Pancreas Transplant
Eligibility:
All Genders
18+ years
Brief Summary
This study will observe donor derived cell free DNA percentages (via the Allosure test) in combined kidney-pancreas transplant recipients to establish both stable and dysfunctional Allosure assay leve...
Detailed Description
Simultaneous kidney-pancreas transplantation is the optimal treatment for select patients with type 1 diabetes and kidney failure. Limited biomarkers are utilized to monitor the health of the allograf...
Eligibility Criteria
Inclusion
- Age ≥18 years
- Kidney-pancreas transplant recipients
- Patient must have stable creatine, lipase, amylase for at least a two month span after transplant OR patient must receive a biopsy within one year post transplant
Exclusion
- Presence of non-renal or pancreas transplanted organ
- Patient is not enrolled within 1 year after transplant
Key Trial Info
Start Date :
February 26 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 31 2024
Estimated Enrollment :
13 Patients enrolled
Trial Details
Trial ID
NCT04777617
Start Date
February 26 2021
End Date
July 31 2024
Last Update
August 7 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Washington University
St Louis, Missouri, United States, 63110